Discontinuation report TEVA-VENLAFAXINE XR
| Report ID | 105537 |
| Drug Identification Number | 02275031 |
| Brand name | TEVA-VENLAFAXINE XR |
| Common or Proper name | VENLAFAXINE XR 75MG CAPS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | DORMANT |
| Active Ingredient(s) | VENLAFAXINE |
| Strength(s) | 75MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100's & 500's |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-02-07 |
| Remaining supply date | 2020-02-07 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Transitioned to the ACT Product |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2020-02-08 | English | Compare |
| v2 | 2020-02-07 | French | Compare |
| v1 | 2020-02-07 | English | Compare |
Showing 1 to 3 of 3